The market ended on a positive note in 2 of those five sessions. ETMarkets highlighted seven stocks from the BSE 100 index that consistently saw price gains during this period.
FPIs sell Rs 24,753 crore in March amid market jitters, but outflows slow down
FPIs have been selling off Indian equities in March, with outflows totalling Rs 24,753 crore as of March 7. The trend has slowed slightly, but cumulative outflows for 2025 have reached over Rs 1.30 lakh crore. Chinese equities’ strong performance and global uncertainties are key factors influencing the FPI movement.
Devina Mehra shares her market wisdom: sectors, themes, global trends
Devina Mehra believes that this is the time to be invested in equity as part of a well-diversified portfolio.
Wall Street ends higher after Fed chief’s comments, but posts big weekly loss
The benchmark S&P 500 finished with its biggest weekly loss since September. The S&P 500 and the Nasdaq also registered their third straight week of declines, the longest losing streak since mid-July and early August last year.
Sebi proposes lower application size for ZCZP
In its consultation paper, Sebi has proposed that minimum application size for ZCZP issuance should be reduced to Rs 5,000 or to a much smaller amount of Rs 1,000 so as to enable more retail participation in ZCZP issuances by NPO on SSE.
Sebi chief bats for full disclosure by its board members
Buch, who led Sebi for three years, came under attack after the now-defunct Hindenburg Research and the Congress party levelled serious allegations against her around conflict of interest. Buch and Sebi issued statements denying these claims.
Markets reversing? Sudip Bandyopadhyay on 5 stocks to consider now
Sudip Bandyopadhyay advises investors to consider SBI, IndusInd Bank, Bharat Electronics, Mankind Pharma, and Piramal Pharma for long-term portfolios. He sees opportunities in these companies due to recent market corrections and positive economic signs. Bandyopadhyay further highlights the potential in banks and pharma, suggesting both conservative and aggressive investment approaches.
Why retail investors should hold cash in volatile markets, Pankaj Pandey explains
Speaking in an ET Now interaction, Pandey emphasized that uncertainty regarding global growth and inflation remains, primarily due to ongoing trade disputes between the world’s two largest economies
Laurus Labs shares in focus after board approves Rs 83.3 crore investment in KRKA Pharma
Laurus Labs has approved an investment of Rs 83.3 crore in the joint venture KRKA Pharma Pvt Ltd to establish a manufacturing facility targeting new markets, including India. KRKA d.d. will also invest Rs 86.7 crore, maintaining the 51:49 shareholding ratio with Laurus Labs.
Wipro shares in focus after launch of AI-first platform TelcoAI360 to help telecom sector cut costs
Developed in collaboration with Wipro’s AI partner ecosystem and leveraging ServiceNow’s telecommunications industry solutions suite, TelcoAI360 is designed to streamline operations, improve network performance, and strengthen security for telecom providers.
